Table 1 Significant proteins (VIP > 1) in the orthogonal partial least square discriminant analysis (OPLS-DA) model of all three compartments (intracutaneous, subcutaneous and intravenous) that contributed most to the separation between the different time periods.
Protein ID | Gene name | Protein name | Compartment | VIP |
|---|---|---|---|---|
P02766 | TTR | Transthyretin | Intracutaneous | 1.37 |
P04217 | A1BG | Alpha-1B-glycoprotein | Subcutaneous | 1.37 |
P00450 | CP | Ceruloplasmin | Subcutaneous | 1.35 |
P02768 | ALB | Albumin | Intracutaneous | 1.35 |
P00738;P00739 | HP | Haptoglobin/haptoglobin-related protein | Subcutaneous | 1.32 |
P02652 | APOA2 | Apolipoprotein A-II | Intracutaneous | 1.31 |
P02768 | ALB | Albumin | Subcutaneous | 1.30 |
P02763 | ORM1 | Alpha-1-acid glycoprotein 1 | Subcutaneous | 1.28 |
P01042 | KNG1 | Kininogen-1 | Subcutaneous | 1.28 |
P43652 | AFM | Afamin | Intracutaneous | 1.27 |
P02652 | APOA2 | Apolipoprotein A-II | Subcutaneous | 1.24 |
P01011 | AACT | Alpha-1-antichymotrypsin | Intravenous | 1.24 |
P02763 | ORM1 | Alpha-1-acid glycoprotein 1 | Intracutaneous | 1.23 |
P02765 | AHSG | Alpha-2-HS-glycoprotein | Intravenous | 1.23 |
P02750 | LRG1 | Leucine-rich alpha-2-glycoprotein | Subcutaneous | 1.23 |
P04217 | A1BG | Alpha-1B-glycoprotein | Intracutaneous | 1.22 |
P02766 | TTR | Transthyretin | Subcutaneous | 1.21 |
Q96PD5 | PGLYRP2 | N-acetylmuramoyl-L-alanine amidase | Subcutaneous | 1.21 |
P01011 | AACT | Alpha-1-antichymotrypsin | Subcutaneous | 1.20 |
P68871 | HBB | Hemoglobin subunit beta | Intracutaneous | 1.20 |
P69905 | HBA1 | Hemoglobin subunit alpha | Intracutaneous | 1.20 |
P02750 | LRG1 | Leucine-rich alpha-2-glycoprotein | Intracutaneous | 1.20 |
P02768 | ALB | Albumin | Intravenous | 1.19 |
O75882 | ATRN | Attractin | Intracutaneous | 1.19 |
P01011 | AACT | Alpha-1-antichymotrypsin | Intracutaneous | 1.18 |
P00738;P00739 | HP | Haptoglobin/haptoglobin-related protein | Intravenous | 1.18 |
P02766 | TTR | Transthyretin | Intravenous | 1.15 |
P25311 | AZGP1 | Zinc-alpha-2-glycoprotein | Subcutaneous | 1.15 |
P02765 | AHSG | Alpha-2-HS-glycoprotein | Subcutaneous | 1.15 |
P02753 | RBP4 | Retinol-binding protein 4 | Intravenous | 1.14 |
P00738;P00739 | HP | Haptoglobin/haptoglobin-related protein | Intracutaneous | 1.14 |
P19652 | ORM2 | Alpha-1-acid glycoprotein 2 | Intracutaneous | 1.14 |
P43251 | BTD | Biotinidase | Intracutaneous | 1.13 |
P68871 | HBB | Hemoglobin subunit beta | Intravenous | 1.13 |
P02765 | AHSG | Alpha-2-HS-glycoprotein | Intracutaneous | 1.12 |
P02760 | AMBP | Protein AMBP | Intracutaneous | 1.11 |
Q9NZP8 | C1RL | Complement C1r subcomponent-like protein | Intracutaneous | 1.11 |
P01019 | AGT | Angiotensinogen | Intracutaneous | 1.11 |
P25311 | AZGP1 | Zinc-alpha-2-glycoprotein | Intracutaneous | 1.09 |
P02763 | ORM1 | Alpha-1-acid glycoprotein 1 | Intravenous | 1.09 |
P00450 | CP | Ceruloplasmin | Intracutaneous | 1.08 |
P01009 | SERPINA1 | Alpha-1-antitrypsin | Intravenous | 1.08 |
P02749 | APOH | Beta-2-glycoprotein 1 | Intracutaneous | 1.08 |
P01042 | KNG1 | Kininogen-1 | Intracutaneous | 1.07 |
P25311 | AZGP1 | Zinc-alpha-2-glycoprotein | Intravenous | 1.06 |
P04217 | A1BG | Alpha-1B-glycoprotein | Intravenous | 1.06 |
P49454 | CENPF | Centromere protein F | Subcutaneous | 1.06 |
O75882 | ATRN | Attractin | Intravenous | 1.05 |
P01019 | AGT | Angiotensinogen | Intravenous | 1.05 |
Q96PD5 | PGLYRP2 | N-acetylmuramoyl-L-alanine amidase | Intracutaneous | 1.05 |
Q9NZP8 | C1RL | Complement C1r subcomponent-like protein | Subcutaneous | 1.04 |
P02787 | TF | Serotransferrin | Intracutaneous | 1.04 |
P02787 | TF | Serotransferrin | Subcutaneous | 1.01 |
P02790 | HPX | Hemopexin | Intravenous | 1.00 |
